Table of Contents

Since its approval, Zepbound (tirzepatide) has become one of the most prescribed injectables for obesity. Unlike pills you take each day, Zepbound is given by injection once a week, and it can come in different delivery options, including single-dose prefilled pens, single-dose vials, multi-dose vials, and a new KwikPen that delivers an entire month’s worth of medicine in one device.

Each option provides the same active ingredient and doses, but the devices differ in how you prepare the injection, how much you pay, and how easy the process feels.

This guide explains how the Zepbound KwikPen compares with vials, focusing on ease of use, cost, and safety.

Key Takeaways

  • All Zepbound forms deliver tirzepatide, so the weight-loss effects and potential adverse events are the same.
  • The KwikPen holds four weekly doses in one device. You attach a new needle, dial the dose, and press the button. It reduces packaging and is easy to travel with.
  • Vials require drawing medication into a syringe. Multi-dose vials are preserved with phenol and benzyl alcohol and last 30 days, while single-dose vials contain no preservatives.
  • Both the KwikPen and single-dose vials cost $299-$699 per month via Lilly’s self-pay program.

Zepbound delivery options

Zepbound is available in several delivery options. All of them contain the same active ingredient and deliver the same doses, but the design and preparation differ.

Single-dose prefilled pen

The original Zepbound device is a single-dose disposable pen. Each prefilled pen delivers one injection of 0.5 mL and is thrown away after use. Because of this, there are no preservatives in the formulation.

You simply remove the cap and press the device firmly against your skin until the injection finishes. There is no need to attach a needle or dial a dose. Single-dose pens are simple to use but require a new device every week, resulting in more packaging waste and a higher list price than other forms.

Single-dose vial

Zepbound also comes in a single-dose vial that contains one 0.5 mL dose of tirzepatide. To use it, you must gather a syringe, needle, alcohol swab, gauze pad and sharps container. After removing the plastic cap and wiping the rubber stopper, you insert a sterile needle and draw out the entire 0.5 mL dose.

You then inject the medicine into your abdomen, thigh, or upper arm. Single-dose vials, like the single-dose pens, contain no preservatives. Each vial must be used immediately once opened and then discarded.

Multi-dose vial

To reduce waste and cost, Lilly also sells multi-dose vials that hold four doses (2.4 mL) and contain preservatives (phenol and benzyl alcohol) along with glycerin.

Each multi-dose vial supplies four 0.6 mL injections that you draw using a syringe. The product must be refrigerated before opening and may be kept at room temperature for up to 30 days after the first use. You must use a new syringe and needle for each dose and wipe the rubber stopper with alcohol each time to avoid contamination.

Multi-dose pen (KwikPen)

The KwikPen is a reusable, multi-dose pen designed to deliver four weekly Zepbound doses. Each KwikPen is prefilled with 2.4 mL of tirzepatide and provides four 0.6 mL injections. It is a single-patient-use device, meaning one person uses the pen for the entire month.

The pen must be primed before the first injection, and you need to attach a new disposable pen needle for each dose. It works much like an insulin pen where you dial the prescribed dose, press the injection button, and wait until the dose counter returns to zero. After four doses, or after 30 days, whichever comes first, you throw away the pen.

Like the multi-dose vial, the KwikPen contains preservatives (phenol and benzyl alcohol) and glycerin for tonicity.

Because the pen holds a month of medication, you only need to pick up one device rather than four separate vials. However, you must purchase your own pen needles (sold separately) and learn how to attach them.

How to use each Zepbound device

Here’s how to use them:

Using the KwikPen

  • Check and prepare the pen: Remove the pen from the refrigerator and let it warm to room temperature (up to 86 °F). Inspect the solution through the window. It should be clear and colorless without particles. Do not use the pen if it is cloudy or frozen. Wash your hands.
  • Attach a new needle: Remove the paper tab from a new pen needle, push the needle straight onto the pen, and twist it until it is tight. Pull off the outer needle cap and inner needle cap.
  • Prime the pen: Turn the dose knob to 0.6 mL (the priming symbol) and press the injection button with the pen pointing upward until a drop of medicine appears at the needle tip. This ensures the pen is ready and removes air bubbles.
  • Dial your dose: Turn the dose knob to your prescribed dose. The pen contains four fixed doses, so you only need to dial to one mark; if you cannot turn the knob, the pen may be empty.
  • Choose an injection site: Clean your abdomen, thigh, or the back of your upper arm with an alcohol swab. Rotate injection sites each week to reduce irritation.
  • Inject: Insert the needle into your skin at a 90-degree angle. Press and hold the injection button until the dose counter shows “0,” and you hear a click. Continue holding the button for about 10 seconds to ensure the full dose is delivered. Remove the needle.
  • Dispose of the needle: Unscrew the needle and throw it into a sharps container. Replace the pen cap and store the pen either in the refrigerator or at room temperature (do not exceed 86 °F).

Using single-dose vials

  • Gather supplies: Single-dose vials require a syringe, needle, alcohol swab, gauze pad, and sharps container. Wash your hands.
  • Prepare the vial: Remove the plastic cap to expose the rubber stopper. Wipe the stopper with an alcohol swab and let it air-dry.
  • Draw up the dose: Attach a new needle to the syringe, pull back the plunger to draw in air equal to 0.5 mL (the dose), and inject the air into the vial. Turn the vial upside down and draw out 0.5 mL of medication. Remove any air bubbles.
  • Choose an injection site: Clean the injection site (abdomen, thigh, or upper arm) with alcohol. Pinch the skin if needed.
  • Inject: Insert the needle at a 45- to 90-degree angle and push the plunger to inject the medicine. Withdraw the needle and apply gentle pressure with gauze.
  • Dispose: Throw away the used syringe and vial in a sharps container. Do not save any leftover medication.

Using multi-dose vials

Multi-dose vials follow similar steps to the single-dose vial, but you have to follow these additional steps:

  • Store properly: Keep unopened vials in the refrigerator. After first use, you may store the vial in the refrigerator or at room temperature (up to 86 °F) for 30 days. Note the date of first use and discard the vial after 30 days or when empty.
  • Use new equipment each time: Always use a new sterile syringe and needle for each dose and wipe the rubber stopper with alcohol before inserting the needle. The vial contains preservatives to keep the solution sterile, but reusing needles can introduce bacteria.
  • Draw and inject: Draw 0.6 mL of medication and inject it into your abdomen, thigh, or upper arm. Rotate sites each time.
  • Dispose properly: Store the vial with its rubber stopper covered, and throw away used syringes in a sharps container.

Ease of use of the Zepbound pen vs. the vial

For many people starting Zepbound, weekly injections are a new experience. Simple, intuitive devices can make adherence easier and reduce anxiety. Ease of use matters especially for patients who are uncomfortable with needles or who travel frequently.

Let’s compare how the KwikPen and vials stack up.

Convenience of the KwikPen

  • One device per month: The KwikPen holds a month of medicine, so you only need to carry one pen and a few needles rather than four separate vials or single-dose pens. This design reduces packaging and simplifies storage. You grab one pen from your refrigerator, and you’re set for four weeks.
  • Familiar operation: If you have ever used an insulin pen, the KwikPen works similarly. You attach a needle, dial the dose, and press the button. There is no need to draw medicine into a syringe, which many people find more comfortable and less error-prone.
  • Portability: Because the pen is compact and lightweight, it is easy to pack in a purse or travel bag. Consolidating four weekly doses into one pen reduces packaging waste and is convenient for travelers.
  • Clear dose indicator: The dose knob clicks into place, and the window shows the dose you selected. This feature helps ensure you deliver the correct amount. The built-in counter also lets you know when the pen is empty.
  • Learning curve: Some users report that the KwikPen has a slight learning curve because you must remember to prime the pen and attach a new needle each time. If you are used to prefilled auto-injectors, the manual dialing could feel less straightforward. Once you have mastered the process, though, it becomes routine.

Convenience of vials

  • Familiar technique: If you have previously injected insulin or other medications using a syringe, vials may feel familiar. You draw the medication into a syringe, adjust the dose, and inject. Many healthcare providers and diabetic patients are comfortable with this method.
  • Flexible dose adjustments: Some people like the ability to measure partial doses. While Zepbound dosing is fixed at increments of 2.5 mg, there may be situations, under guidance from a physician, where you need to temporarily adjust the dose. A vial allows you to draw a smaller volume if necessary. In contrast, the KwikPen delivers only fixed doses, and you cannot adjust the amount.
  • Minimal device training: Unlike the KwikPen, there is no priming step. You simply insert the needle, draw the medicine, and inject. However, you must keep track of how much is left in a multi-dose vial, and you must handle needles and syringes safely.
  • Less packaging than single-dose pens: A multi-dose vial contains four doses in one small bottle. This reduces waste compared with four single-dose pens. Compared with the KwikPen, however, you still need to carry syringes and needles.

Cost comparison of Zepbound pens vs. vials

Eli Lilly set the list price of the single-dose prefilled pen at around $1,086 per month. Meanwhile, the company offered 4-count single-dose vials and single-patient-use KwikPens under a self-pay program through LillyDirect at much lower prices:

    • $299 per month for the 2.5 mg starting dose
    • $399 per month for 5 mg
    • $499 per month for 7.5 mg
    • $699 per month for the higher doses (10 mg, 12.5 mg, and 15 mg)

However, vials are not eligible for insurance or manufacturer coupons. You’ll have to pay cash through LillyDirect or certain telehealth providers.

A media statement in March 2026 announced that the KwikPen would be available at major pharmacies nationwide in addition to LillyDirect. Lilly introduced a KwikPen Self-Pay Savings Card that allows patients without insurance coverage to pay the same self-pay price at local pharmacies. Importantly, the card applies only to the KwikPen and does not cover single-dose vials or prefilled pens. This change expanded access for patients who prefer to pick up prescriptions locally instead of relying on mail-order services.

Additional cost considerations

Additional expenses may include:

    • Needles and syringes: The KwikPen requires separate pen needles, while vials require syringes and needles. These supplies add a modest cost. Some insurance plans cover them, but if not, they can cost $10-$30 per month.
    • Alcohol swabs: Used to clean the injection site before each dose. Usually inexpensive, around $3-$10 per month.
    • Sharps disposal container: Needed for safe disposal of used needles and syringes. A one-time purchase is about $5-$15, though some pharmacies or programs provide them for free.
    • Travel and portability supplies: If you travel frequently, you may need supplies like insulated medication cases, ice packs, and organizers. They are typically a one-time cost of $30-$80, though premium options can reach $100-$200+, with minimal ongoing monthly expense.

Safety considerations of Zepbound pens and vials

All Zepbound devices deliver tirzepatide, so the safety profile is the same regardless of the device. Whether you use a vial or a pen, you must watch for serious adverse effects.

Stop the medication and seek care if you experience severe stomach pain that does not go away, signs of gallbladder problems (pain in the upper abdomen, fever, yellowing skin), or symptoms of a serious allergic reaction (swelling of the face or throat, trouble breathing).

Injection site reactions and preservatives

Clinical trials found injection-site reactions in about 6-8% of participants taking Zepbound, compared with 2% in those receiving a placebo. There’s no data comparing injection-site reactions across devices, but because the same formulation is used, expect similar rates.

If you’re sensitive to phenol or benzyl alcohol, know that these preservatives are present in multi-dose vials and the KwikPens. Single-dose vials and pens do not contain preservatives.

Storage and handling

Proper storage is essential for safety. Unopened pens and vials should be kept in the refrigerator between 36 °F and 46 °F (2-8 °C). Do not freeze them.

Multi-dose pens and vials may be stored at room temperature (up to 86 °F) after first use and must be discarded after 30 days, even if medicine remains. Single-dose pens and vials may be stored at room temperature for up to 21 days.

Always use a new needle or syringe and never share your pen or vial with another person, as this can spread infection. Do not try to transfer medication from a pen or vial into a syringe.

Regardless of the device, you should:

    • Rotate injection sites every week to prevent irritation.
    • Store and discard properly according to the product instructions.
    • Use new needles/syringes each time and never share devices.
    • Watch for side effects and report anything concerning to your provider.

Environmental impact of pens vs. vials

Choosing between devices has environmental implications. The single-dose pen creates the most waste because each injection requires an entirely new device. Four pens per month equals more plastic and cardboard.

The single-dose vial uses less plastic but still involves four glass vials per month. In contrast, the multi-dose vial and the KwikPen each hold four doses in one container. Patients who want to minimize waste may prefer the multi-dose options.

One thing to consider is that the KwikPen still requires disposable pen needles, and multi-dose vials require disposable syringes. These supplies should be disposed of in a sharps container and handled according to local regulations. Some pharmacies or health departments offer sharps disposal programs. Reducing overall waste can be part of a broader effort to manage chronic diseases responsibly.

Bottom line

Zepbound is an effective injectable weight-management option, available in both pen and vial forms. The KwikPen offers convenience and portability, while vials provide flexibility but require more supplies and handling. Since all forms contain the same medication, the best choice depends on your preferences, cost, and comfort with injections.

Consult your healthcare provider to determine the right option for you, and follow proper storage and injection guidelines. With the right approach and support, Zepbound can be a valuable tool for achieving and maintaining a healthier weight.

Frequently Asked Questions

Yes. Single-dose vials and pens contain identical tirzepatide formulations with the same excipients, dose strength, and injection volume.

The KwikPen is a single-patient-use multi-dose pen preloaded with four weekly 0.6 mL doses. To use it, you only need to attach a pen needle, dial the dose, and inject. A vial requires drawing a 0.5 mL or 0.6 mL dose with a separate syringe.

As of early 2026, LillyDirect’s self-pay program prices both the four-dose KwikPen and single-dose vials the same, from $299 per month for the 2.5 mg starter and up to $699 for higher doses.

Each KwikPen contains four fixed doses (2.4 mL total) of tirzepatide and delivers a 0.6 mL injection once a week for a month.

Zepbound (tirzepatide) is available in single-dose pens, single-dose vials, multi-dose vials, and the single-patient-use multi-dose pen (KwikPen). All provide the same medication.

Articles you may also be interested in

Sources

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen | Eli Lilly and Company. (n.d.). Eli Lilly and Company. https://investor.lilly.com/news-releases/news-release-details/zepbound-tirzepatide-most-prescribed-weight-management

U.S. Food and Drug Administration. (2023, November 15). How to Use Zepbound® | Dosing & Administration. U.S. Food And Drug Administration. https://zepbound.lilly.com/weight/how-to-use

Is the formulation of Zepbound® (tirzepatide) the same in pens and vials? (n.d.). https://medical.lilly.com/us/products/answers/is-the-formulation-of-zepbound-tirzepatide-the-same-in-pens-and-vials-241495

Constantino, A. K. (2026, February 24). Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen. CNBC. https://www.cnbc.com/2026/02/23/eli-lilly-launches-zepbound-obesity-drug-pen-one-month-doses.html

Zepbound Cost Information | With or Without Insurance | Zepbound® (tirzepatide) injection. (n.d.). https://pricinginfo.lilly.com/zepbound